###begin article-title 0
Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 120 122 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 264 266 264 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 363 367 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+) </sup>
###xml 415 417 415 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 767 769 767 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Phosphatidylinositol 4,5-bisphosphate (PIP2) is required for successful completion of cytokinesis. In addition, both PIP2 and phosphoinositide-specific phospholipase C (PLC) have been localized to the cleavage furrow of dividing mammalian cells. PLC hydrolyzes PIP2 to yield diacylglycerol (DAG) and inositol trisphosphate (IP3), which in turn induces calcium (Ca2+) release from the ER. Several studies suggest PIP2 must be hydrolyzed continuously for continued cleavage furrow ingression. The majority of these studies employ the N-substituted maleimide U73122 as an inhibitor of PLC. However, the specificity of U73122 is unclear, as its active group closely resembles the non-specific alkylating agent N-ethylmaleimide (NEM). In addition, the pathway by which PIP2 regulates cytokinesis remains to be elucidated.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 254 256 254 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Here we compared the effects of U73122 and the structurally unrelated PLC inhibitor ET-18-OCH3 (edelfosine) on cytokinesis in crane-fly and Drosophila spermatocytes. Our data show that the effects of U73122 are indeed via PLC because U73122 and ET-18-OCH3 produced similar effects on cell morphology and actin cytoskeleton organization that were distinct from those caused by NEM. Furthermore, treatment with the myosin light chain kinase (MLCK) inhibitor ML-7 caused cleavage furrow regression and loss of both F-actin and phosphorylated myosin regulatory light chain from the contractile ring in a manner similar to treatment with U73122 and ET-18-OCH3.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 188 190 188 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
We have used multiple inhibitors to examine the roles of PLC and MLCK, a predicted downstream target of PLC regulation, in cytokinesis. Our results are consistent with a model in which PIP2 hydrolysis acts via Ca2+ to activate myosin via MLCK and thereby control actin dynamics during constriction of the contractile ring.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 260 262 260 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 303 305 303 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 326 328 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 386 390 386 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+) </sup>
###xml 422 425 422 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 507 510 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Cell proliferation and growth require the coordination of cell signaling pathways. PLC plays an important role in cell signaling, mediating transduction of signals from a variety of intracellular and extracellular stimuli [1,2]. PLC-dependent hydrolysis of PIP2 produces the second messengers DAG and IP3 (reviewed in [3]). IP3 binds specific receptors on the ER to mobilize calcium (Ca2+) from internal stores. DAG and Ca2+ activate protein kinase C (PKC), which stimulates cell growth [4]. In addition, Ca2+ itself facilitates diverse cellular events including membrane trafficking, contractility and proliferation [5]. PLC-dependent pathways thus play key roles in promoting cell growth.
###end p 9
###begin p 10
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 267 269 267 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 437 439 437 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
The synthetic aminosteroid U73122 (Figure 1A) is an important tool in identifying and studying PLC-dependent processes. Initially discovered in a search for inhibitors of platelet activation, U73122 was found to inhibit PLC function [6]. U73122 causes decreases in IP3 and DAG production, calcium levels, and phosphatidylinositol (PI) turnover in agonist-stimulated platelets, indicating that U73122 blocks PLC-mediated hydrolysis of PIP2 in treated cells [7]. The mechanism of action of U73122 is currently unknown [8], although an examination of its structure can provide some insight into the biologically active domains of the molecule. The inhibitory activity of U73122 can be reduced by alteration of the C17 side chain or removal of the 3-methoxy group [7]. Substitution of the electrophilic maleimide group of U73122 with the less electrophilic succinimide produces the inactive isomer U73343, which differs from the active form only by the absence of a double bond on the pyrrole ring (Figure 1B). Thus, reactivity appears to reside largely in the NEM moiety of the molecule. NEM (Figure 1C) is a sulfhydryl alkylating agent that covalently modifies cysteine residues, raising the possibility that U73122 acts by a similar mechanism.
###end p 10
###begin p 11
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chemical structures of PLC inhibitors and controls</bold>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Chemical structures of PLC inhibitors and controls. Chemical structures of (A) U73122, (B) U73343, (C) NEM and (D) ET-18-OCH3.
###end p 11
###begin p 12
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 285 287 285 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 524 526 524 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Using inhibitors affecting PI metabolism, we previously showed that continuous PI cycling is required for cytokinesis [9]. In particular, treatment of cells with U73122 resulted in regression of the cleavage furrow and failure of cytokinesis [9,10]. The effects of U73122 suggested PIP2 hydrolysis is required for normal cytokinesis. Indeed, cytokinesis failed in cells treated with an IP3 receptor antagonist or in which intracellular Ca2+ was chelated by BAPTA-AM [10]. Perhaps most strikingly, our data indicated that PIP2 hydrolysis may be required to maintain F-actin in the contractile ring [9].
###end p 12
###begin p 13
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 704 707 704 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 764 766 764 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 187 193 <span type="species:ncbi:9986">rabbit</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 598 601 <span type="species:ncbi:10116">rat</span>
###xml 799 802 <span type="species:ncbi:10116">rat</span>
###xml 831 834 <span type="species:ncbi:10116">rat</span>
U73122 may exert non-specific effects, however, because several lines of evidence suggest that U73122 may affect phosphoinositide cycling or Ca2+ levels independent of PLC inhibition. In rabbit platelets, U73122 caused up to 50% reduction in the levels of phosphatidylinositol 4-phosphate (PIP) and PIP2, but not PI, indicating that U73122 may inhibit both PI and PIP kinases. Although IP3 levels were reduced in agonist-stimulated cells, consistent with inhibition of PLC, this may have been an indirect effect of a shortage in substrate availability [11]. In U73122-treated mouse fibroblasts and rat neutrophils, inhibition of Ca2+ influx across the plasma membrane contributed to the suppression of Ca2+ levels [12,13]. In contrast, U73122 actually increased Ca2+ release from internal stores in rat pancreatic acinar cells and rat liver microsomes [14,15].
###end p 13
###begin p 14
###xml 70 72 70 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 189 191 189 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 344 346 344 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 472 474 472 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 687 689 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 618 623 <span type="species:ncbi:9606">human</span>
###xml 661 664 <span type="species:ncbi:10116">rat</span>
A second PLC inhibitor, the lysophosphatidylcholine analogue ET-18-OCH3 (Figure 1D; [16]), is of interest in cancer therapy because of its demonstrated anti-tumor properties [17]. ET-18-OCH3 and related compounds inhibit phosphatidylinositol 3-kinases and PKC [18-21] and selectively promote tumor cell apoptosis [17,22]. Like U73122, ET-18-OCH3 also has other off-target effects, including release of Ca2+ from intracellular stores [23]. However, unlike U73122, ET-18-OCH3 is inserted in the plasma membrane, and its effects may be due in part to alteration of membrane lipid and protein composition [24-26]. In both human histiocytic lymphoma and tumorigenic rat liver cells, ET-18-OCH3 inhibits cytokinesis [27,28].
###end p 14
###begin p 15
###xml 110 112 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
To determine if U73122 inhibits cytokinesis via PLC, we compared the effects of U73122 with those of ET-18-OCH3 and NEM. We further examined the role of a potential downstream target of PLC activity, MLCK. We found that inhibition of MLCK perturbed cytokinesis in a manner similar to inhibition of PLC by U73122 and ET-18-OCH3. Our results are consistent with a model in which PLC and MLCK act in the same pathway to maintain the integrity of the contractile ring, implicating MLCK as a target of Ca2+ regulation in this process.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
PLC inhibition causes cleavage furrows to regress
###end title 17
###begin p 18
###xml 121 145 121 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 321 326 321 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, D, F</xref>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 804 815 804 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1098 1108 1098 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1230 1231 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 121 144 <span type="species:ncbi:7227">Drosophila melanogaster</span>
We previously showed that the PLC inhibitor U73122 caused cleavage furrow regression during cytokinesis in crane-fly and Drosophila melanogaster spermatocytes [9,10]. In control cells, cytokinesis was initiated by invagination of the equatorial plasma membrane to form a furrow between the nascent daughter cells (Figure 2A, B) [see Additional files 1, 2] [10,29]. Ingression continued unabated until the cleavage furrow reached a minimum diameter of one to several micrometers (Figure 2E). When added after initiation of furrowing, U73122 arrested cytokinesis and caused cleavage furrow regression (Figure 2C, D, F) [see Additional files 3, 4] [9,10]. During cleavage, mitochondria and parafusorial membranes along the spindle become constricted as the plasma membrane ingressed at the equator [10]. In Drosophila spermatocytes treated with U73122, these structures remained constricted as the plasma membrane regressed, and often underwent continued constriction of several micrometres after regression of the furrow (Figure 2D). The effects of U73122 were not reversible at any concentration in Drosophila; however, in crane-fly spermatocytes, the effects at the minimum effective dosage of U73122 were reversed after washing [9].
###end p 18
###begin p 19
###xml 58 69 58 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U73122 causes cleavage furrow regression in crane-fly and <italic>Drosophila </italic>spermatocytes</bold>
###xml 183 194 183 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 334 345 333 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 419 420 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 422 423 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 520 531 519 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 848 859 844 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 990 1001 986 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
U73122 causes cleavage furrow regression in crane-fly and Drosophila spermatocytes. (A, B) Phase-contrast images showing time-course of cytokinesis in untreated (A) crane-fly and (B) Drosophila spermatocytes [see Additional files 1, 2]. Times are in min:sec. Bars, 10 mum. (C, D) Phase-contrast time-course of a (C) crane-fly and (D) Drosophila spermatocyte treated with U73122 during cytokinesis [see Additional files 3, 4]. U73122 was added immediately after the time-point depicted in the second panel. Crane-fly and Drosophila spermatocytes were treated with 4.3 muM and 10 muM U73122 respectively. Note that the crane-fly spermatocyte was followed for only a short time after treatment (for a longer time-course, see [9]). Bars, 10 mum. (E) Plot of the change in cell diameter (ordinate) over time (abscissa) for the treated crane-fly (+) and Drosophila (o) spermatocytes shown in A, B. (F) Plot of the change in cell diameter (ordinate) over time (abscissa) for the crane-fly (+) and Drosophila (o) spermatocytes shown in C, D. Arrows indicate time of drug treatment.
###end p 19
###begin p 20
###xml 95 106 95 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 163 165 163 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 237 245 237 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, B, C</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 342 353 341 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 375 377 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 485 496 483 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 600 602 598 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
To determine if a second PLC inhibitor had a similar effect, we treated dividing crane-fly and Drosophila spermatocytes with ET-18-OCH3. In both species, ET-18-OCH3 inhibited cytokinesis and caused the cleavage furrow to regress (Figure 3A, B, C) [see Additional files 5, 6]. These effects were seen at concentrations of 30 muM or greater in Drosophila spermatocytes (Figure 3D) and 35 muM or greater in crane-fly spermatocytes (data not shown). In crane-fly spermatocytes, but not in Drosophila spermatocytes, cleavage furrow regression was reversible in 2/4 treated cells. Thus U73122 and ET-18-OCH3 have similar effects on cytokinesis.
###end p 20
###begin p 21
###xml 9 11 9 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 62 73 62 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ET-18-OCH<sub>3 </sub>causes cleavage furrow regression in crane-fly and <italic>Drosophila </italic>spermatocytes</bold>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 190 201 190 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 275 277 274 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 455 466 453 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 558 569 556 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 635 636 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 751 752 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
ET-18-OCH3 causes cleavage furrow regression in crane-fly and Drosophila spermatocytes. (A, B) Time-lapse phase-contrast micrographs showing ET-18-OCH3-treated dividing (A) crane-fly or (B) Drosophila spermatocytes [see Additional files 5, 6]. For each cell, 35 muM ET-18-OCH3 was added just after the time-point depicted in the second panel. Bars, 10 mum. (C) Plot of the change in cell diameter (ordinate) over time (abscissa) for the crane-fly (+) and Drosophila (o) spermatocytes shown in A, B. Arrows indicate time of drug addition. (D). Sensitivity of Drosophila spermatocyte cytokinesis to increasing concentrations of ET-18-OCH3. Cytokinesis failed in the majority of cells treated with 30 muM and in all cells treated with 35-40 muM ET-18-OCH3.
###end p 21
###begin title 22
Alkylation stops furrow ingression but does not cause regression
###end title 22
###begin p 23
###xml 197 208 197 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 307 312 307 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 653 655 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 661 672 660 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 797 802 796 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, C</xref>
###xml 880 882 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 917 918 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
To determine if the effects of U73122 were due to non-specific alkylation of off-target proteins, we directly examined the effects of the alkylating agent NEM on cytokinesis. In both crane-fly and Drosophila spermatocytes, NEM stopped cytokinesis but did not cause regression of the cleavage furrow (Figure 4A, B) [see Additional files 7, 8]. The effective concentration differed between the two species. In crane-fly spermatocytes, NEM inhibited furrowing at concentrations of 50 muM or greater. Cleavage arrest occurred immediately after treatment and cleavage furrows did not regress or resume constriction even after the drug was washed out (Figure 4C). In Drosophila spermatocytes, NEM also irreversibly stopped furrowing, although it was effective at concentrations as low as 500 nM (Figure 4B, C). In addition, NEM caused large blebs to form on the plasma membrane (Figure 4B, arrowheads) [see Additional file 8]. NEM did not cause regression of cleavage furrows at any concentration tested (up to 100 muM).
###end p 23
###begin p 24
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Treatment with NEM blocks cytokinesis but does not cause cleavage furrow regression</bold>
###xml 216 217 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 226 237 225 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 423 434 421 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 477 478 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 593 604 590 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Treatment with NEM blocks cytokinesis but does not cause cleavage furrow regression. (A, B) Time-lapse phase-contrast images showing a dividing (A) crane-fly spermatocyte treated with 50 muM NEM [see Additional file 7] or (B) Drosophila spermatocyte treated with 10 muM NEM. In both experiments, cells were treated just after the time-point depicted in the second panel. Note the appearance of blebs after treatment of the Drosophila spermatocyte (arrows) [see Additional file 8]. Bars, 10 mum. (C) Plot of the change in cell diameter (ordinate) over time (abscissa) for the crane-fly (+) and Drosophila (o) spermatocytes shown in A, B. NEM was added at the time-point indicated by the left arrow. In the crane-fly spermatocyte, cleavage remained arrested even after washing with Insect Ringers (right arrow).
###end p 24
###begin title 25
Myosin Light Chain Kinase (MLCK) inactivation causes cleavage furrows to regress
###end title 25
###begin p 26
###xml 13 15 13 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 288 290 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 327 338 326 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 398 408 395 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 451 453 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 463 465 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 488 489 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 505 516 502 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 576 578 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 601 602 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 644 646 641 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 778 789 775 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 874 876 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 961 963 958 960 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
To test if IP3 receptor-mediated Ca2+ release activates MLCK during cytokinesis [10], we examined the effects of ML-7, an inhibitor of MLCK and hence of myosin activation. A concentration range of 75-80 muM was chosen because lower concentrations had little or no effect on cytokinesis ([29]; not shown). In both crane-fly and Drosophila spermatocytes, treatment with 75 muM (crane-fly) or 80 muM (Drosophila) ML-7 caused cleavage furrow regression ([29]; Figure 5A) [see Additional file 9]. Treatment of Drosophila spermatocytes with ML-7 was reversible upon washout (Figure 5B) [see Additional file 9], unlike treatment with U73122, ET-18-OCH3 or NEM; however, after resuming, ingression arrested prematurely in 21 out of 33 cells. Thus, the effects of ML-7 on cytokinesis in Drosophila spermatocytes are identical to those previously reported in crane-fly spermatocytes [29]. That ML-7 treatment blocks cytokinesis in a manner similar to U73122 and ET-18-OCH3 is consistent with PLC and MLCK acting in the same pathway.
###end p 26
###begin p 27
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Treatment with ML-7 causes cleavage furrow regression</bold>
###xml 85 96 85 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 387 398 385 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 526 527 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
Treatment with ML-7 causes cleavage furrow regression. (A) Time-course of a dividing Drosophila spermatocyte treated with 80 muM ML-7 just after the time-point depicted in the second panel. The cell was washed with Insect Ringer's buffer just after the time-point depicted in the fourth panel. Bar, 10 mum. (B) Plot of the change in cell diameter (ordinate) over time (abscissa) for the Drosophila spermatocyte shown in A. Time-points of ML-7 addition (left arrow) and washout (right arrow) are indicated [see Additional file 9].
###end p 27
###begin title 28
PLC and MLCK activities are required to maintain actin at the cleavage furrow
###end title 28
###begin p 29
###xml 399 405 399 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, A'</xref>
###xml 694 700 694 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B, B'</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 743 745 743 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 895 901 895 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C, C'</xref>
###xml 1024 1025 1024 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1278 1284 1278 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D, D'</xref>
###xml 1683 1689 1683 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E, E'</xref>
To investigate the effect of the various inhibitors on cytoskeletal components, we stained crane-fly spermatocytes for F-actin and tubulin. In control cells, actin filaments were arranged in a circumferential band around the equator of the cell, with very little F-actin at the poles. Tubulin was present in spindle and astral microtubules and was organized longitudinally from pole-to-pole (Figure 6A, A'). After treatment with U73122, tubulin organization was similar to that of control cells. However, actin filaments became much shorter and more disorganized, with many cells showing reduction in F-actin at the cleavage furrow concomitant with accumulation of F-actin at the poles (Figure 6B, B'; see also [9]). Similarly, after ET-18-OCH3 treatment, F-actin accumulated at the poles, with the few actin filaments at the equator appearing more sparsely packed than in control cells (Figure 6C, C'). After treatment with ML-7, the distribution of F-actin and tubulin closely resembled treatment with U73122 and ET-18-OCH3: tubulin localization was unchanged as compared to control cells, whereas F-actin disappeared from the contractile ring and accumulated at the poles. These actin filaments were longer than in U73122-treated cells and appeared more disorganized (Figure 6D, D'). In contrast, treatment with NEM had an entirely different effect: astral microtubules were absent and F-actin in the contractile ring was dramatically reduced, with the majority of cells (5/7) showing a compact band of F-actin at the equator. In addition, F-actin did not accumulate at the poles. Actin filaments in the cortex were broken into small fragments or completely depolymerized (Figure 6E, E').
###end p 29
###begin p 30
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F-actin relocalizes from the contractile ring to the poles upon inhibition of PLC or MLCK</bold>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
F-actin relocalizes from the contractile ring to the poles upon inhibition of PLC or MLCK. Confocal images of dividing crane-fly spermatocytes stained for (A-E) F-actin and (A'-E') tyrosinated tubulin. (A, A') Untreated control cell. In untreated cells, F-actin was concentrated in the contractile ring (A) and tubulin in the spindle (A'). (B, B') Cell treated with U73122. (C, C') Cell treated with ET-18-OCH3. (D, D') Cell treated with ML-7. Cells treated with these inhibitors had reduced contractile ring F-actin and accumulation of F-actin at the poles (B-D). (E, E') Cell treated with NEM. Note small band of F-actin at the equator, as well as reduced F-actin density throughout the rest of the cell. Also note loss of astral microtubules (E'). Bar, 10 mum.
###end p 30
###begin title 31
PLC and MLCK activities are required to maintain activated myosin
###end title 31
###begin p 32
###xml 110 120 110 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 173 184 173 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 552 554 552 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B&#8211;D</xref>
To directly test if these inhibitors interfered with phosphorylation of myosin regulatory light chain (Sqh in Drosophila; [30]), a known target of MLCK, we stained dividing Drosophila spermatocytes for phosphorylated Sqh (phospho-Sqh; [31]) and F-actin. In control cells, phospho-Sqh strongly colocalized with F-actin in the contractile ring, weakly colocalized with F-actin on the cell cortex at the poles, and was found weakly colocalized with the mitochondria and parafusorial membranes (Figure 7A). In contrast, cells treated with U73122, ET-18-OCH3 or ML-7 no longer showed evidence of phospho-Sqh or F-actin in the contractile ring. Instead, phospho-Sqh remained associated with the mitochondria and parafusorial membranes, whereas F-actin accumulated at the poles of the cell (Figure 7B-D).
###end p 32
###begin p 33
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of PLC or MLCK causes loss of phosphorylated myosin regulatory light chain from the contractile ring</bold>
###xml 170 181 170 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 419 420 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Inhibition of PLC or MLCK causes loss of phosphorylated myosin regulatory light chain from the contractile ring. Phase-contrast and immunofluorescence images of dividing Drosophila spermatocytes stained for phospho-Sqh (green), F-actin (red) and DNA (blue). (A) Untreated control cell. Note colocalization of phospho-Sqh and F-actin in the contractile ring. (B) Cell treated with U73122. (C) Cell treated with ET-18-OCH3. (D) Cell treated with ML-7. (B-C) In cells treated with these inhibitors, phospho-Sqh and F-actin were no longer evident at the equator, whereas F-actin was relocalized to the poles. Bar, 10 mum.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1106 1107 1106 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1148 1159 1148 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
U73122 is widely accepted as a specific inhibitor of PLC. Nevertheless, its mechanism of action has yet to be elucidated. In some systems, NEM mimics treatment with U73122 [32], raising the possibility that previously reported effects of U73122 were due to alkylation of off-target proteins rather than inhibition of PLC. To obtain such effects with NEM, Horowitz et al. treated cells with concentrations of NEM forty-times larger than those used for U73122. The authors suggested that higher concentrations of NEM were required because NEM lacks the lipophilic steroid domain of U73122 that targets the NEM moiety to membranes [32]. Consistent with their observations, we found that the concentration required for NEM to block cytokinesis in crane-fly spermatocytes was twenty-times greater than the minimum effective concentration of U73122. However, unlike U73122, NEM did not cause regression of the cleavage furrow or redistribution of F-actin to the poles of the cell. In addition, the effect of U73122 on cytokinesis was reversible in crane-fly spermatocytes at the minimum effective concentration [9], whereas the effect of NEM was not. In Drosophila spermatocytes, on the other hand, NEM stopped cleavage furrow ingression at a concentration well below the effective concentration of U73122 [10], suggesting that NEM has more pleiotropic effects. Indeed, NEM treatment resulted in blebbing of the plasma membrane, an effect not seen after treatment with U73122. These observations show that the effects of U73122 are distinct from those of NEM, and suggest that they are due to inhibition of PLC by U73122, although our data do not rule out a mechanism in which U73122 inhibits PLC by alkylation. Effects of other inhibitors strengthen the argument that a PLC-dependent pathway is involved in cytokinesis.
###end p 35
###begin p 36
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 172 174 172 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 421 432 421 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 590 593 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 904 907 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 928 939 928 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1039 1041 1039 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1093 1095 1093 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1124 1127 1124 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1252 1254 1252 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
A second PLC inhibitor, ET-18-OCH3, had effects on cytokinesis similar to U73122. ET-18-OCH3 is believed to act by inserting into cellular membranes. Like U73122, ET-18-OCH3 caused cleavage furrow regression and redistribution of F-actin to the poles of the cell. These inhibitors have two known overlapping cellular effects: inhibition of PLC and release of Ca2+ from intracellular stores. In previous experiments using Drosophila spermatocytes, we showed that treatments predicted to greatly influence intracellular Ca2+ levels had little effect on cytokinesis. Treatment of cells with Ca2+ ionophores A23187 or ionomycin did not block cleavage, although they did induce cell contractility and occasional ectopic cell fusion events [10]. In contrast, chelation of intracellular Ca2+ with the cell permeable chelator BAPTA-AM did block cytokinesis, but only when cells were cultured in buffer lacking Ca2+ [10]. Thus, at least Drosophila spermatocytes can divide provided they have either an intracellular or an extracellular source of Ca2+, rendering it unlikely that any effect of ET-18-OCH3 or U73122 on intracellular Ca2+ stores would have blocked cytokinesis in these cells. The simplest explanation for the common effect of U73122 and ET-18-O-CH3 is that PLC activity is required for cytokinesis.
###end p 36
###begin p 37
###xml 238 240 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 241 243 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 351 353 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 409 411 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 427 428 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 530 532 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 533 535 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 598 600 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The requirement for PLC activity in cytokinesis appears to be conserved. Several mammalian PLC isoforms, PLCdelta1, PLCbeta1 and PLCdelta3, were found to localize to the cleavage furrows of HeLa, NIH3T3 and MDCK cells during cytokinesis [33,34]. Moreover, PLCgamma is tyrosine phosphorylated, and presumably activated, in dividing sea urchin embryos [35]. U73122, which blocks cleavage in sea urchin embryos [35], and ET-18-OCH3, which was originally found to interfere with cytokinesis in transformed cells and tumor cell lines [27,28], were recently found to inhibit cytokinesis in NIH3T3 cells [34]. Although there are currently no genetic studies showing a role for individual PLCs in cytokinesis in any system, this is likely due to redundancy, as most organisms contain multiple PLCs.
###end p 37
###begin p 38
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 290 292 290 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 323 334 323 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 424 426 424 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 499 501 499 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 586 597 586 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 720 723 720 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 802 805 802 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 840 842 840 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 615 624 <span type="species:ncbi:7955">zebrafish</span>
In dividing crane-fly and Drosophila spermatocytes, two PLC inhibitors, U73122 and ET-18-OCH3, cause cleavage furrow regression ([9][10]; this study). Inhibition of PLC would be expected to result in an increase in PIP2, concomitant with a decrease in the second messengers DAG and IP3. PIP2 is required for cytokinesis in Drosophila spermatocytes and mammalian cells [10,36,37]. However, it is unclear if an increase in PIP2 would be deleterious to the cell. On the other hand, inhibition of the IP3 receptor with 2-APB or chelation of Ca2+ with BAPTA-AM blocked continued cleavage in Drosophila spermatocytes and zebrafish embryos [10,38,39]. Furthermore, we previously showed that treatment of spermatocytes with a Ca2+ ionophore prevented the cells from responding to U73122, strongly suggesting Ca2+ is a key downstream effector of PIP2 hydrolysis during cytokinesis [10]. Effects of the MLCK inhibitor ML-7 confirm this interpretation.
###end p 38
###begin p 39
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 536 547 536 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 925 927 925 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1143 1152 1143 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1153 1156 1153 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g</italic>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 409 415 <span type="species:ncbi:171251">citron</span>
MLCK, a potential target of Ca2+ during cytokinesis, phosphorylates myosin regulatory light chain on Ser-19, and to a lesser extent on Thr-18. This diphosphorylation activates non-muscle myosin II, allowing it to form bipolar thick filaments postulated to constrict F-actin in the contractile ring [40-42]. Although recent experiments have focused on roles for other myosin activating kinases, Rho kinase and citron kinase, in cytokinesis [43], MLCK may also have a crucial role in this process. Indeed, treatment of both crane-fly and Drosophila spermatocytes with the MLCK inhibitor ML-7 reversibly blocked cytokinesis ([29]; this study). Similarly, ML-7 interferes with cytokinesis in sea urchin embryos [44] and with maintenance of F-actin in the contractile ring in mammalian cells [45]. Strikingly, ML-7 caused cleavage furrow regression and redistribution of actin filaments in a manner similar to U73122 and ET-18-OCH3 (this report). Furthermore, treatment with all three inhibitors caused loss of phosphorylated myosin regulatory light chain (phospho-Sqh) from the equator of the cell. Although ML-7 is reported to have other targets in vitro (e.g., PKA and PKC; [46]), the most straightforward interpretation of our results is that all three inhibitors interfere with cytokinesis by blocking MLCK activity, myosin regulatory light chain phosphorylation and myosin II contractility.
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 356 358 356 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
We showed that two different PLC inhibitors, U73122 and ET-18-OCH3, have similar effects on cleavage furrow stability, F-actin localization and myosin regulatory light chain phosphorylation, indicating a role for PLC activity in cleavage furrow ingression. Moreover, inhibition of MLCK with ML-7 affects cytokinesis in a similar manner, suggesting that PIP2 hydrolysis and Ca2+ release stimulate non-muscle myosin II to maintain actin-myosin interactions and stability of the contractile ring.
###end p 41
###begin title 42
Methods
###end title 42
###begin title 43
Live spermatocyte preparation
###end title 43
###begin p 44
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 217 238 217 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nephrotoma suturalis </italic>
###xml 262 286 262 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 360 361 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 377 379 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 394 395 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 262 285 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 652 658 <span type="species:ncbi:9913">bovine</span>
Preparation of crane-fly spermatocytes in fibrin clots has been described in detail elsewhere [47]; a modified protocol was used to examine Drosophila spermatocytes [10]. Briefly, testes from fourth instar crane-fly (Nephrotoma suturalis (Loew)) or third instar Drosophila melanogaster were dissected in Insect Ringer's buffer (0.13 M NaCl, 5 mM KCl, 1 mM CaCl2, and 5 mM KH2PO4 and 7 mM Na2HPO4.7H2O, pH 6.8) and transferred to a small drop of 3-10% fibrinogen in Insect Ringer's buffer on a glass coverslip. Testes were then pierced with an insect needle, allowing the cells to flow out. After waiting ~30 seconds for the cells to settle, 2-5 mul of bovine thrombin was added to form a clot. The clot was inverted onto a drop of Insect Ringer's buffer in a perfusion chamber and sealed with wax or silicon grease. Cells were perfused with Insect Ringer's buffer (with or without pharmacological agents) throughout the experiment.
###end p 44
###begin title 45
Cell treatments
###end title 45
###begin p 46
###xml 326 328 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
All experiments were performed at room temperature (25degreesC). Stock solutions of 0.01 M U73122 (1-[6-[[17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione; Calbiochem) or U73343 (1-[6-[[17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione; Calbiochem), 0.03 M ET-18-OCH3 (1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine; Biomol Research Laboratories, Inc., Plymouth Meeting, PA), 0.05 M ML-7 (1-[5-Iodonaphthalene-1-sulfonyl]-1H-hexahydro-l,4-diazepine.HCl; Sigma-Aldrich) or 6 M NEM (Sigma-Aldrich) were prepared in dimethylsulfoxide (DMSO) (Sigma-Aldrich) and stored at -20degreesC. Prior to treatment, aliquots of each drug were thawed and diluted to the appropriate final concentration with Insect Ringer's buffer. To ensure that any observed effects were not due to the solvent, control cells were treated with the same final concentration of DMSO.
###end p 46
###begin title 47
Phase-contrast and fluorescence microscopy
###end title 47
###begin p 48
###xml 5 16 5 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Live Drosophila spermatocytes were imaged using an upright Zeiss Axioplan 2 microscope with a Zeiss Apochromat 100x oil immersion objective lens (NA 1.4). Phase-contrast and fluorescent images were recorded with an Axiocam CCD camera using AxioVision software for image acquisition. Live crane-fly spermatocytes were followed using a phase-contrast inverted Nikon microscope with a Nikon 100x oil-immersion objective (NA 1.3). Real-time images were recorded on videotape or on DVD.
###end p 48
###begin title 49
Immunostaining and fluorescence microscopy
###end title 49
###begin p 50
###xml 44 55 44 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 126 137 126 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 246 257 246 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 732 734 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 793 804 792 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 415 421 <span type="species:ncbi:9986">rabbit</span>
###xml 679 682 <span type="species:ncbi:10116">rat</span>
Immunostaining and imaging of crane-fly and Drosophila spermatocytes were performed essentially as described [48] except that Drosophila spermatocytes were fixed with 4% paraformaldehyde (Electron Microscopy Sciences) rather than glutaraldehyde. Drosophila spermatocytes were stained with Alexa 488 phalloidin (Molecular Probes) for F-actin, 4',6-diamidino-2-phenylindole (DAPI; Molecular Probes) for DNA and 1:400 rabbit polyclonal antibody against phospho-Ser19-Sqh (from Luke Alphey [31]) and were mounted in Fluorescence Mounting Medium (Daxocytomation). Crane-fly spermatocytes were stained using 2.2 muM Alexa 488 phalloidin for F-actin (Molecular Probes) and 1:4000 YL1/2 rat monoclonal antibody against tyrosinated tubulin [46] and were mounted in Mowiol. Immunofluorescence images of Drosophila spermatocytes were collected with a Zeiss Axioplan 2 microscope and Axiovision 4.2 software. Confocal images of crane-fly spermatocytes were collected with Fluoview (Olympus) software, and were processed further using Image J (public domain software available at ) and Adobe Photoshop. All illustrations were prepared using Adobe Photoshop and were adjusted for image presentation only (brightness, contrast).
###end p 50
###begin title 51
Analysis of data
###end title 51
###begin p 52
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Cleavage furrow ingression was measured from individual frames extracted from time-lapsed recordings using custom software and plotted using SlideWrite as described previously [9,10].
###end p 52
###begin title 53
Abbreviations
###end title 53
###begin p 54
DAG diacylglycerol
###end p 54
###begin p 55
DMSO dimethylsulfoxide
###end p 55
###begin p 56
###xml 9 11 9 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
ET-18-OCH3 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine; edelfosine (PLC inhibitor)
###end p 56
###begin p 57
F-actin filamentous actin
###end p 57
###begin p 58
###xml 2 4 2 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
IP3 inositol trisphosphate
###end p 58
###begin p 59
ML-7 1-[5-Iodonaphthalene-1-sulfonyl]-1H-hexahydro-l,4-diazepine.HCl (MLCK inhibitor)
###end p 59
###begin p 60
MLCK myosin light chain kinase
###end p 60
###begin p 61
NEM N-ethylmaleimide
###end p 61
###begin p 62
PI phosphatidylinositol
###end p 62
###begin p 63
PIP phosphatidylinositol 4-phosphate
###end p 63
###begin p 64
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
PIP2 phosphatidylinositol 4,5-bisphosphate
###end p 64
###begin p 65
PLC phospholipase C
###end p 65
###begin p 66
###xml 22 33 22 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Sqh Spaghetti squash (Drosophila myosin regulatory light chain)
###end p 66
###begin p 67
U73122 1-[6-[[17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (PLC inhibitor)
###end p 67
###begin p 68
U73343 1-[6-[[17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione (inactive isomer of U73122)
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
RW designed and carried out the Drosophila experiments and drafted the manuscript. LF designed and carried out the crane-fly experiments and commented on the manuscript. AF participated in the design of the study, analysis of the data, and helped edit the manuscript. JAB conceived the study, participated in its design and edited the manuscript. All authors read and approved the final manuscript.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional file 1
###end title 72
###begin p 73
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
Meiosis in a crane-fly spermatocyte. Time-lapse phase-contrast micrographs of a dividing crane-fly primary spermatocyte. Times are hr:min:s. Movie corresponds to Figure 2A.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 2
###end title 75
###begin p 76
###xml 13 24 13 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 90 101 90 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
Meiosis in a Drosophila spermatocyte. Time-lapse phase-contrast micrographs of a dividing Drosophila primary spermatocyte. Mitochondria and parafusorial membranes appear dark and outline the spindle during meiosis. Times are hr:min:s:ms. Movie corresponds to Figure 2B.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 3
###end title 78
###begin p 79
###xml 310 312 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
Inhibition of PLC with U73122 causes cleavage furrow regression in a dividing crane-fly spermatocyte. Dividing crane-fly spermatocyte treated with 4.3 muM U73122 at 1 min 36 sec (14:51:00). Note that this cell was followed for only a short time after treatment. Times are hr:min:s. Movie corresponds to Figure 2C.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 4
###end title 81
###begin p 82
###xml 78 89 78 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 112 123 112 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 259 261 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
Inhibition of PLC with U73122 causes cleavage furrow regression in a dividing Drosophila spermatocyte. Dividing Drosophila spermatocyte treated with 10 muM U73122 at 3 min 20 sec and washed at 18 min 20 sec. Times are hr:min:s:ms. Movie corresponds to Figure 2D.
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 5
###end title 84
###begin p 85
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 167 169 166 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 230 232 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
Inhibition of PLC with ET-18-OCH3 causes cleavage furrow regression in a dividing crane-fly spermatocyte. Dividing crane-fly spermatocyte treated with 35 muM ET-18-OCH3 at 13:32:00. Times are hr:min:s. Movie corresponds to Figure 3A.
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Additional file 6
###end title 87
###begin p 88
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 82 93 82 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 116 127 116 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 169 171 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 240 242 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
Inhibition of PLC with ET-18-OCH3 causes cleavage furrow regression in a dividing Drosophila spermatocyte. Dividing Drosophila spermatocyte treated with 35 muM ET-18-OCH3 at 5 min. 35 sec. Times are hr:min:s:ms. Movie corresponds to Figure 3B.
###end p 88
###begin p 89
Click here for file
###end p 89
###begin title 90
Additional file 7
###end title 90
###begin p 91
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
The alkylating agent NEM inhibits cytokinesis in a dividing crane-fly spermatocyte. Dividing crane-fly spermatocyte treated with 1 mM NEM at 15:02:00. Times are hr:min:s. Movie corresponds to Figure 4A.
###end p 91
###begin p 92
Click here for file
###end p 92
###begin title 93
Additional file 8
###end title 93
###begin p 94
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 94 105 94 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 223 225 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
The alkylating agent NEM inhibits cytokinesis in a dividing Drosophila spermatocyte. Dividing Drosophila spermatocyte treated with 1 muM NEM at 2 min 21 sec. Times are hr:min:s:ms. Cell treated similarly is shown in Figure 4B.
###end p 94
###begin p 95
Click here for file
###end p 95
###begin title 96
Additional file 9
###end title 96
###begin p 97
###xml 77 88 77 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 111 122 111 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 303 305 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
Inhibition of MLCK with ML-7 causes cleavage furrow regression in a dividing Drosophila spermatocyte. Dividing Drosophila spermatocyte treated with 80 muM ML-7 at 3 min 30 sec. After the cell is washed at 4 min 55 sec, furrowing resumes. Times are hr:min:s:ms. Cell treated similarly is shown in Figure 5A.
###end p 97
###begin p 98
Click here for file
###end p 98
###begin title 99
Acknowledgements
###end title 99
###begin p 100
###xml 99 101 99 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
The authors gratefully acknowledge Daniel Saul for carrying out initial experiments using ET-18-OCH3 on crane-fly spermatocytes, Luke Alphey for providing anti-phospho-Sqh antibody and John Ashkenas for comments on the manuscript. This research was generously supported by Ontario Graduate Scholarships (to RW and to LF), SickKids Restracomp funding (to RW), a Discovery Grant from the Canadian Natural Sciences and Engineering Research Council (to AF) and a Terry Fox Foundation grant from the National Cancer Institute of Canada (to JAB).
###end p 100
###begin article-title 101
Phosphoinositide-specific phospholipase C and mitogenic signaling
###end article-title 101
###begin article-title 102
Phosphoinositide metabolism and hormone action
###end article-title 102
###begin article-title 103
Phosphoinositide-derived messengers in endocrine signaling
###end article-title 103
###begin article-title 104
Preclinical and clinical development of novel agents that target the protein kinase C family
###end article-title 104
###begin article-title 105
The versatility and universality of calcium signalling
###end article-title 105
###begin article-title 106
###xml 40 45 <span type="species:ncbi:9606">human</span>
Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness
###end article-title 106
###begin article-title 107
###xml 80 85 <span type="species:ncbi:9606">human</span>
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils
###end article-title 107
###begin article-title 108
Pharmacology of phosphoinositides, regulators of multiple cellular functions
###end article-title 108
###begin article-title 109
Continuous phosphatidylinositol metabolism is required for cleavage of crane fly spermatocytes
###end article-title 109
###begin article-title 110
PIP2 hydrolysis and calcium release are required for cytokinesis in Drosophila spermatocytes
###end article-title 110
###begin article-title 111
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 146 152 <span type="species:ncbi:9986">rabbit</span>
U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets
###end article-title 111
###begin article-title 112
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Calcium homeostasis in mouse fibroblast cells: affected by U-73122, a putative phospholipase C beta blocker, via multiple mechanisms
###end article-title 112
###begin article-title 113
U-73122, an aminosteroid phospholipase C inhibitor, may also block Ca2+ influx through phospholipase C-independent mechanism in neutrophil activation
###end article-title 113
###begin article-title 114
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
Phospholipase C inhibitor, U73122, releases intracellular Ca2+, potentiates Ins(1,4,5)P3-mediated Ca2+ release and directly activates ion channels in mouse pancreatic acinar cells
###end article-title 114
###begin article-title 115
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Effect of the aminosteroid, U73122, on Ca2+ uptake and release properties of rat liver microsomes
###end article-title 115
###begin article-title 116
Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues
###end article-title 116
###begin article-title 117
ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor
###end article-title 117
###begin article-title 118
Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues
###end article-title 118
###begin article-title 119
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
###end article-title 119
###begin article-title 120
ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells
###end article-title 120
###begin article-title 121
Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha
###end article-title 121
###begin article-title 122
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells
###end article-title 122
###begin article-title 123
The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells
###end article-title 123
###begin article-title 124
Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step
###end article-title 124
###begin article-title 125
Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells
###end article-title 125
###begin article-title 126
Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition
###end article-title 126
###begin article-title 127
Inhibition of cell division but not nuclear division by 1-O- octadecyl-2-O-methyl-Sn-glycero-3-phosphocholine
###end article-title 127
###begin article-title 128
###xml 36 39 <span type="species:ncbi:10116">rat</span>
Growth suppression of a tumorigenic rat liver cell line by the anticancer agent, ET-18-O-CH(3), is mediated by inhibition of cytokinesis
###end article-title 128
###begin article-title 129
Effects of anti-myosin drugs on anaphase chromosome movement and cytokinesis in crane-fly primary spermatocytes
###end article-title 129
###begin article-title 130
The regulatory light chain of nonmuscle myosin is encoded by spaghetti squash, a gene required for cytokinesis in Drosophila
###end article-title 130
###begin article-title 131
The essential role of PP1beta in Drosophila is to regulate nonmuscle myosin
###end article-title 131
###begin article-title 132
Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current
###end article-title 132
###begin article-title 133
Coordinated intracellular translocation of phosphoinositide-specific phospholipase C-delta with the cell cycle
###end article-title 133
###begin article-title 134
Phospholipase C isoforms are localized at the cleavage furrow during cytokinesis
###end article-title 134
###begin article-title 135
Movement of membrane domains and requirement of membrane signaling molecules for cytokinesis
###end article-title 135
###begin article-title 136
PtdIns(4,5)P2 functions at the cleavage furrow during cytokinesis
###end article-title 136
###begin article-title 137
Local change in phospholipid composition at the cleavage furrow is essential for completion of cytokinesis
###end article-title 137
###begin article-title 138
###xml 71 80 <span type="species:ncbi:7955">zebrafish</span>
Multiple types of calcium signals are associated with cell division in zebrafish embryo
###end article-title 138
###begin article-title 139
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
Ca2+ released via IP3 receptors is required for furrow deepening during cytokinesis in zebrafish embryos
###end article-title 139
###begin article-title 140
Cytokinesis
###end article-title 140
###begin article-title 141
Control of nonmuscle myosins by phosphorylation
###end article-title 141
###begin article-title 142
Phosphorylation of a second site for myosin light chain kinase on platelet myosin
###end article-title 142
###begin article-title 143
Regulation of myosin II during cytokinesis in higher eukaryotes
###end article-title 143
###begin article-title 144
A global, myosin light chain kinase-dependent increase in myosin II contractility accompanies the metaphase-anaphase transition in sea urchin eggs
###end article-title 144
###begin article-title 145
Myosin-II-dependent localization and dynamics of F-actin during cytokinesis
###end article-title 145
###begin article-title 146
Effects of inhibitors of myosin light chain kinase and other protein kinases on the first cell division of sea urchin eggs.
###end article-title 146
###begin article-title 147
Fibrin clots keep non-adhering living cells in place on glass for perfusion or fixation
###end article-title 147
###begin article-title 148
Redundant mechanisms for anaphase chromosome movements: crane-fly spermatocyte spindles normally use actin filaments but also can function without them
###end article-title 148

